-
Challenges in implementing model-based phase I designs in a grant-funded clinical trials unit.
Journal article
Frangou E. et al, (2017), Trials, 18
-
Overall survival in the FOXFIRE-SIRFLOX-FOXFIRE Global prospective randomized studies of first-line SIRT in patients with mCRC
Conference paper
Wasan HS. et al, (2017)
-
Overall survival in the FOXFIRE-SIRFLOX-FOXFIRE global prospective randomized studies of first-line SIRT in patients with mCRC
Conference paper
Wasan H. et al, (2017), ANNALS OF ONCOLOGY, 28
-
Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma.
Journal article
Buas MF. et al, (2017), Gut, 66, 1739 - 1747
-
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials.
Journal article
Wasan HS. et al, (2017), Lancet Oncol, 18, 1159 - 1171
-
Quality of life in patients with liver metastases from colorectal cancer treated with first-line selective internal radiotherapy (SIRT): Results from the FOXFIRE prospective randomized studies
Conference paper
Gray AM. et al, (2017), ANNALS OF ONCOLOGY, 28
-
FOXFIRE-SIRFLOX-FOXFIRE global prospective randomised studies of first-line selective internal radiotherapy (SIRT) in patients with liver metastases from colorectal cancer: KRAS mutation and tumour site analysis
Conference paper
Wasan H. et al, (2017), ANNALS OF ONCOLOGY, 28
-
Embracing model-based designs for dose-finding trials.
Journal article
Love SB. et al, (2017), Br J Cancer, 117, 332 - 339
-
SCALOP-2: A multi-centre randomised study of induction chemotherapy followed by capecitabine (+/- nelfinavir) with high or standard dose radiotherapy for locally advanced non-metastatic pancreatic cancer
Conference paper
Virdee PS. et al, (2017), Annals of Oncology